Fusion Pharmaceuticals Inc logo

FUSN - Fusion Pharmaceuticals Inc News Story

$8.21 0.3  3.3%

Last Trade - 28/07/21

Sector
Healthcare
Size
Small Cap
Market Cap £243.3m
Enterprise Value £79.5m
Revenue £n/a
Position in Universe 4114th / 7000

BRIEF-Fusion Pharmaceuticals Announces Fourth Quarter 2020 Results

Thu 25th March, 2021 11:40am
March 25 (Reuters) - Fusion Pharmaceuticals Inc  FUSN.O :
    * FUSION PHARMACEUTICALS ANNOUNCES FOURTH QUARTER 2020
FINANCIAL
RESULTS AND BUSINESS UPDATE
    * Q4 LOSS PER SHARE $0.32
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.22 -- REFINITIV IBES
DATA
    * FUSION PHARMACEUTICALS - EXPECTS CASH, CASH EQUIVALENTS &
INVESTMENTS AS OF DEC. 31, 2020 WILL ENABLE CO TO FUND ITS
OPERATIONS THROUGH END OF 2023

Source text for Eikon:  ID:nCNWKX69Ha 
Further company coverage:  FUSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.